IMAX

IMAX emerges as the stronger movie theater stock, backed by premium cinema technology, global expansion, low leverage and a more attractive valuation than AMC.

Imax (IMAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Imax (IMAX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Imax (IMAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Corporate insurgencies hit a fever pitch this month—and October is only half over. We break down, and size up, five of the biggest dramas.

IMAX Corp (NYSE:IMAX) is on track to report record third-quarter results, prompting Wedbush to raise its price target on the stock to $60 from $54 and reiterate its Outperform rating.

AMC stock has doubled in 2025 while still carrying nearly $4 billion in debt and negative stockholders' equity, leaving investors to weigh whether a landmark refinancing buys enough time for box office momentum to close that gap.

IMAX Corporation has treated shareholders to a strong run in recent years, which naturally raises a question for anyone looking at the stock today.

Christopher Nolan’s The Odyssey is returning to select IMAX (IMAX) theaters, giving the format renewed attention as audiences get another chance to see the $1.7b film in its intended presentation.

Christopher Nolan’s blockbuster The Odyssey, the first major film shot entirely with IMAX film cameras and grossing over US$1.70 billion worldwide, has already returned for a limited run in select IMAX theaters, giving audiences another chance to see it in…